MUNA THERAPEUTICS
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
MUNA THERAPEUTICS
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.munatherapeutics.com
Status:
Active
Total Funding:
73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Maps Typekit Kriesi.at
Similar Organizations
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Employees Featured
Niels Plath Chief Scientific Officer @ Muna Therapeutics
Chief Scientific Officer
2021-01-01
Simon Glerup Founder @ Muna Therapeutics
Founder
Rita Balice-Gordon Chief Executive Officer @ Muna Therapeutics
Chief Executive Officer
Stefan Lohmer Board Observer @ Muna Therapeutics
Board Observer
2021-07-01
Anders Hinsby Chief Operating Officer @ Muna Therapeutics
Chief Operating Officer
Bart De Strooper Founder @ Muna Therapeutics
Founder
Founder
Investors List
Novo Holdings
Novo Holdings investment in Series A - Muna Therapeutics
LS Polaris Innovation Fund
LS Polaris Innovation Fund investment in Series A - Muna Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series A - Muna Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - Muna Therapeutics
V-Bio Ventures
V-Bio Ventures investment in Series A - Muna Therapeutics
Droia Ventures
Droia Ventures investment in Series A - Muna Therapeutics
VIB
VIB investment in Series A - Muna Therapeutics
LSP BioVentures
LSP BioVentures investment in Series A - Muna Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Muna Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-11-01 | Muna Therapeutics Appoints Dr. Niels Plath as Chief Scientific Officer |
Official Site Inspections
http://www.munatherapeutics.com Semrush global rank: 7.27 M Semrush visits lastest month: 547
- Host name: afa7f374f51cc8991.awsglobalaccelerator.com
- IP address: 3.33.186.135
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109

More informations about "Muna Therapeutics"
Muna Therapeutics | A bold vision of resilience to treat ...
Nov 1, 2021 · Muna Therapeutics discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s and Parkinson’s.See details»
About Us - Muna Therapeutics
We integrate scientific insights from human genetics, bioinformatic analyses of molecular pathways affected in disease, and human cell biology to uncover new ways to repair neuronal function, resolve chronic neuroinflammation, restore …See details»
Our Science | Muna Therapeutics
We transform groundbreaking science into life-changing therapies that preserve cognition and other brain functions and enhance resilience to neurodegeneration. Our name reflects our focus on preserving key brain functions, like cognition, …See details»
Muna Therapeutics - Crunchbase Company Profile
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Parkinson's, Alzheimer's, Frontotemporal Dementia, and Multiple …See details»
Muna Therapeutics - LinkedIn
Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark. Muna discovers and develops therapies that slow or stop devastating...See details»
Muna Therapeutics Launches with US$ 73M Series A to Advance …
COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ -- Muna Therapeutics ("Muna"), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, …See details»
Muna Therapeutics Launches with US$ 73M Series A to Advance …
Copenhagen, Denmark, 9th July 2021 – Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, …See details»
Muna Therapeutics - LinkedIn
Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark. Muna discovers and develops therapies that slow or stop devastating...See details»
Muna Therapeutics - VentureRadar
"Muna Therapeutics is a private biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark and Leuven, Belgium. Muna discovers and develops therapies that …See details»
Muna Therapeutics - EQT Group
Nov 18, 2024 · munatherapeutics.com. Sector. Healthcare. Country. Denmark. Fund. LSP Dementia. Entry. 2021. Web. munatherapeutics.com. Latest news. 22 November 2024 EQT …See details»
Team Page - Muna Therapeutics
Our team has years of neurology drug discovery and development experience in the pharmaceutical and biotechnology arenas and is supported by world-class scientific founders …See details»
Novo Holdings Launches Muna Therapeutics with US$ 73M Series …
Jul 9, 2021 · Muna Therapeutics is a private biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark. Muna discovers and develops therapies that slow or stop …See details»
Muna Therapeutics: hopeful solutions for memory loss - BioVox
Oct 17, 2023 · Muna Therapeutics is developing transformative therapies for neurodegenerative diseases. These drugs aim to preserve cognition and enhance the brain’s resilience in …See details»
Muna raises $73M to go after Alzheimer's, Parkinson's and MS
Jul 9, 2021 · Muna Therapeutics has raised $73 million to develop small-molecule treatments for Alzheimer’s and other neurodegenerative diseases. The series A will bankroll work on drugs to …See details»
Novo Holdings Launches Muna Therapeutics with US$ 73M Series …
Jul 9, 2021 · Muna Therapeutics is a private biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark. Muna discovers and develops therapies that slow or stop …See details»
Muna Therapeutics Awarded $4.9M Grant from The Michael J. Fox ...
Muna is focused on addressing the staggering unmet medical need experienced by Parkinson’s patients around the world with its transformative, therapeutic all-in-human target discovery and …See details»
Muna Therapeutics Launches with US$ 73M Series A to Advance
Jul 9, 2021 · Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today announced the successful …See details»
Muna Therapeutics - Craft
Muna Therapeutics is a provider of transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases. It discovers and develops small-molecule …See details»
News - Muna Therapeutics
Sep 13, 2021 · Copenhagen, Denmark and Boston, US 13th September 2021 – Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule …See details»
Careers - Muna Therapeutics
We transform groundbreaking science into life-changing medicines for patients with neurodegenerative disorders. We believe science is driven by curiosity, and that great science …See details»